Document is current
Any future updates will be listed below
-
Authors
Anisuzzaman, D. M.
Malins, Jeffrey G.
Jackson, John I.
Lee, Eunjung
Naser, Jwan A.
Rostami, Behrouz
Bird, Jared G.
Spiegelstein, Dan
Amar, Talia
Ngo, Christie C.
Oh, Jae K.
Pellikka, Patricia A.
Thaden, Jeremy J.
Lopez-Jimenez, Francisco
Poterucha, Timothy J.
Friedman, Paul A.
Pislaru, Sorin V.
Kane, Garvan C.
Attia, Zachi I.
- License Information
-
More Information
Article History
Received: 16 July 2025
Accepted: 5 December 2025
First Online: 1 April 2026
Competing interests
: D.A., J.G.M., J.I.J., E.L., J.A.N., S.V.P., G.C.K., and Z.I.A. have invented algorithms licensed to UltraSight Ltd. and may benefit from algorithm commercialization via Mayo Clinic. D.S. and T.A. are both employees of UltraSight Ltd. F.L.-J. is a member of the Scientific Advisory Board for UltraSight Ltd. P.A.P. received research support from the American Society of Echocardiography Foundation, Ultromics Ltd., GE Healthcare, and Edwards Lifesciences (all funds paid to Mayo Clinic). P.A.P. is also a consultant/advisor for Astellas Pharma. T.J.P. received research support from the American Heart Association, the Amyloidosis Foundation, Eidos Therapeutics, Pfizer, Janssen, and Edwards Lifesciences. T.J.P. also owns stock in Abbott Laboratories and Baxter International. P.A.F., F.L.-J., and Z.I.A. are members of the Scientific Advisory Board for Anumana, an AI company commercializing AI-ECG. F.L.-J. is a co-inventor of several algorithms using AI-ECG licensed to Anumana and a co-inventor of an artificial heart valve that has been licensed to Colibri Co. The remaining authors have nothing to disclose.
